2000
DOI: 10.1006/bbrc.2000.2348
|View full text |Cite
|
Sign up to set email alerts
|

Substrate Binding to 15β-Hydroxylase (CYP106A2) Probed by FT Infrared Spectroscopic Studies of the Iron Ligand CO Stretch Vibration

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
34
1
1

Year Published

2000
2000
2022
2022

Publication Types

Select...
6
2
1

Relationship

5
4

Authors

Journals

citations
Cited by 56 publications
(36 citation statements)
references
References 23 publications
0
34
1
1
Order By: Relevance
“…Evaluation of the levels of correctly folded recombinant P450 was carried out by determining the CO-reduced difference spectra (9,40). The cells were grown in Terrific broth alone or with the heme precursor, ALA, or with ALA and FeCl 3.…”
Section: Resultsmentioning
confidence: 99%
“…Evaluation of the levels of correctly folded recombinant P450 was carried out by determining the CO-reduced difference spectra (9,40). The cells were grown in Terrific broth alone or with the heme precursor, ALA, or with ALA and FeCl 3.…”
Section: Resultsmentioning
confidence: 99%
“…Interestingly, abietic acid-like the steroidal substrates of CYP106A2 [21] -did not induce a type I spectrum during binding. This property had been observed with CYP106A2 and the substrate deoxycorticosterone and afterwards was also noticed for the binding of substrates to other P450s.…”
Section: Substrate Predictionmentioning
confidence: 92%
“…Expression and purification of CYP106A2 were performed as described in the literature. [12,21] The protein concentration was calculated with use of E 414 = 9.8 mm À1 cm À1 for adrenodoxin , [29] E 450 = 11.3 mm À1 cm À1 for adrenodoxin reductase, [30] and E 417 = 91 mm À1 cm À1 for CYP106A2. [12] Automated library screening: A library consisting of 16 671 small molecules was screened.…”
mentioning
confidence: 99%
“…[66] Bacterial expression and purification of recombinant CYP106A2 and mutants: The CYP106A2 cDNA was a kind gift from Dr. Raimund Rauschenbach (Schering AG, Berlin, Germany). Expression of CYP106A2 was performed as described in Simgen et al [67] Purification was performed according to Lisurek et al [6] Site directed mutagenesis: Mutagenesis of residues S394, A395, T396, G397 and Q398 was accomplished according to the protocol of the Quick Change Site-Directed Mutagenesis kit (Stratagene, La Jolla, CA, USA) by using oligonucleotide primers that were synthesised by MWG Biotech AG (Ebersberg, Germany) and the plasmid CYP106A2/pKKHC (NcoI/HindIII). [68] The three mutants I86T, E90V/ D185G and K27R/I71T/I215T were obtained by using a modified plasmid CYP106A2/pKKHC (KpnI/SalIII).…”
Section: Methodsmentioning
confidence: 99%